Granite Point Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-12,000	Closed	-$297K	–	76
2014 Q3	$297K	Hold	12,000	–	–	0.15%	72
2014 Q2	$271K	Sell	12,000 -4,400	-27%	-$99.4K	0.19%	78
2014 Q1	$399K	Sell	16,400 -8,600	-34%	-$209K	0.29%	83
2013 Q4	$625K	Buy	+25,000	New	+$625K	0.1%	77